| Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... Nature 593 (7858), 266-269, 2021 | 1108 | 2021 |
| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1087 | 2021 |
| SARS-CoV-2 evolution during treatment of chronic infection SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ... Nature 592 (7853), 277-282, 2021 | 944 | 2021 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 827 | 2022 |
| Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021 | 702 | 2021 |
| Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ... Cell 184 (5), 1171-1187. e20, 2021 | 565 | 2021 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 434 | 2021 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 358 | 2021 |
| Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 E Alm, EK Broberg, T Connor, EB Hodcroft, AB Komissarov, ... Eurosurveillance 25 (32), 2001410, 2020 | 256 | 2020 |
| An integrated national scale SARS-CoV-2 genomic surveillance network T COVID The Lancet Microbe, 2020 | 175 | 2020 |
| Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant P Elliott, D Haw, H Wang, O Eales, CE Walters, KEC Ainslie, C Atchison, ... Science 374 (6574), eabl9551, 2021 | 121 | 2021 |
| A diverse panel of hepatitis C virus glycoproteins for use in vaccine research reveals extremes of monoclonal antibody neutralization resistance RA Urbanowicz, CP McClure, RJP Brown, T Tsoleridis, MAA Persson, ... Journal of virology 90 (7), 3288-3301, 2016 | 71 | 2016 |
| Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19 S Capone, A Raggioli, M Gentile, S Battella, A Lahm, A Sommella, ... Molecular Therapy 29 (8), 2412-2423, 2021 | 55 | 2021 |
| Discovery of novel alphacoronaviruses in European rodents and shrews T Tsoleridis, O Onianwa, E Horncastle, E Dayman, M Zhu, T Danjittrong, ... Viruses 8 (3), 84, 2016 | 54 | 2016 |
| Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection RA Urbanowicz, T Tsoleridis, HJ Jackson, L Cusin, JD Duncan, ... Science translational medicine 13 (609), eabj0847, 2021 | 46 | 2021 |
| The impact of real-time whole-genome sequencing in controlling healthcare-associated SARS-CoV-2 outbreaks RV Francis, H Billam, M Clarke, C Yates, T Tsoleridis, L Berry, N Mahida, ... The Journal of infectious diseases 225 (1), 10-18, 2022 | 36 | 2022 |
| Shared common ancestry of rodent alphacoronaviruses sampled globally T Tsoleridis, JG Chappell, O Onianwa, DA Marston, AR Fooks, ... Viruses 11 (2), 125, 2019 | 36 | 2019 |
| Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission LB Snell, CL Fisher, U Taj, O Stirrup, B Merrick, A Alcolea-Medina, ... Clinical Microbiology and Infection 28 (1), 93-100, 2022 | 27 | 2022 |
| HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19 S Astbury, CJ Reynolds, DK Butler, DC Muñoz‐Sandoval, KM Lin, ... Immunology 166 (1), 68-77, 2022 | 24 | 2022 |
| Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United Kingdom JG Chappell, T Tsoleridis, G Clark, L Berry, N Holmes, C Moore, M Carlile, ... Journal of General Virology 102 (6), 001595, 2021 | 18 | 2021 |
Jonathan BallLSTM and University of Nottingham在 LSTMed.ac.uk 的电子邮件经过验证
